Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The N-methyl-D-aspartate (NMDA) receptor is an ionotropic glutamate receptor that serves as a critical excitatory neurotransmitter receptor in the central nervous system. It plays an integral role in synaptic plasticity and is particularly notable for its permeability to calcium ions. NMDA receptors are heterotetrameric complexes composed of different combinations of subunits from three distinct gene families: GluN1, GluN2 (A-D), and GluN3 (A-B). They are essential for long-term potentiation (LTP) and long-term depression (LTD), cellular mechanisms underlying learning and memory. Dysfunction of NMDA receptors has been implicated in various neurological and psychiatric disorders, including neurodegenerative diseases, epilepsy, and schizophrenia.
Ligand-gated ion channel; requires glutamate and glycine (or D-serine) binding for activation. Blocked by magnesium ions at resting membrane potentials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor ionotropic, NMDA subtype (NMDAR).